Maintaining sinus rhythm after cardioversion: 7 trials - EURIDIS - ADONIS - DAFNE - EURIDIS ADONIS (pooled analysis) - ATHENA - DIONISOS - PALLAS
| dronedarone vs amiodarone | No demonstrated result suggested Adverse events leading to treatment discontinuation by 52% (not demonstrated) | |
| dronedarone vs placebo | No demonstrated result suggested death or hospitalization for cardiac causes by 15% (not demonstrated) suggested cardiovascular events by 16% (not demonstrated) suggested Cardiovascular death by 29% (not demonstrated) suggested stroke (fatal and non fatal) by 135% (not demonstrated) suggested Atrial fibrillation recurrence by 29% (not demonstrated) suggested Cardiac arrhythmic death by 45% (not demonstrated) suggested hospitalization for AF by 34% (not demonstrated) suggested Adverse events leading to treatment discontinuation by 55% (not demonstrated) |
All type of heart failure: 1 trials - ANDROMEDA
| dronedarone vs placebo | No demonstrated result suggested All cause death by 113% (not demonstrated) |
-
About
-
Browse pathology
|
treatment
-
Site map
-
Credits
Made with in Lyon
-
Contact us
-
Privacy policy
-
